Valley Brook Capital Group, Inc. Abbott Laboratories Transaction History
Valley Brook Capital Group, Inc.
- $128 Million
- Q2 2024
A detailed history of Valley Brook Capital Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Valley Brook Capital Group, Inc. holds 10,750 shares of ABT stock, worth $1.21 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
10,750
Previous 10,775
0.23%
Holding current value
$1.21 Million
Previous $1.22 Million
8.74%
% of portfolio
0.87%
Previous 0.96%
Shares
13 transactions
Others Institutions Holding ABT
# of Institutions
3,135Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.36 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.07 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.43 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...